OpenLegislation

Annex II Summary of product characteristics referred to in Article 10F1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 1Division 1
  2. 2Division 2
  3. 3Division 3
  4. 4Division 4
  5. 5Division 5
  6. 6Division 6
  7. 7Division 7
  8. 8Division 8
  9. 9Division 9
  10. 10Division 10

Annotations

Textual amendments

F1

Regulation revoked (in so far as it applies to medicinal products for human use) (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(o) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)